Business Context and Reporting Period
This Form 8-K is a current report filed by Enochian BioSciences Inc. (not Lunai Bioworks Inc.) on October 21, 2022, regarding an event that occurred on October 17, 2022. The company is incorporated in Delaware and its common stock (ticker: ENOB) is listed on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a regulatory notice and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The material change reported is a compliance failure with Nasdaq listing standards:
- Non-Compliance: The company received a notice from Nasdaq stating it is no longer in compliance with Listing Rule 5250(c)(1) because it has not yet filed its required Form 10-K.
- Immediate Status: The notice has no immediate effect on the listing of the company's shares.
- Delisting Risk: If the company fails to regain compliance, its common stock will be subject to delisting from Nasdaq.
Outlook, Risks, and Contingencies
Compliance Timeline and Process:
- The company has 60 calendar days to submit a plan to Nasdaq to regain compliance.
- If Nasdaq accepts the plan, the company may be granted up to 180 days from the original Form 10-K due date to file the report.
- If the plan is rejected, the company has the opportunity to appeal the decision to a Nasdaq Hearings Panel.
Risks: The primary risk is the potential delisting of the company's stock from Nasdaq if the Form 10-K is not filed and a compliance plan is not approved within the specified timelines.
Investor Verification Checklist
- Verify the exact due date for the missing Form 10-K to calculate the 60-day window for submitting a compliance plan.
- Monitor for the submission of a compliance plan to Nasdaq within the 60-day period.
- Check for any subsequent filings (e.g., Form 10-K or additional 8-Ks) regarding the status of the compliance plan or an appeal to the Nasdaq Hearings Panel.
- Confirm the company's current stock trading status on Nasdaq to ensure no suspension has occurred.